Skip to content
WeighLab

OurView Health vs REMEVi

Compare the prices, treatment options and tradeoffs that matter before you choose a GLP-1 program.

By The WeighLab Bench. Provider verification dates appear below.

OurView Health

Provider comparison

Patients who want a published flat dose price and can choose monthly or prepaid quarterly billing.

Semaglutide / month
$109/moAny dose, compounded; $297 prepaid for three months
Tirzepatide / month
$129/moAny dose, compounded; $357 prepaid for three months
Index 83/100 · Grade BChecked October 2026

Compounded drugs are not FDA-approved. Understand the medication options.

Check OurView Health pricing Read review

REMEVi

Provider comparison

Spanish- and English-speaking shoppers who want LegitScript-certified compounded GLP-1 care in their own language.

Semaglutide / month
$199 per 4 weeksMonth-to-month, same at every dose; $159 per 4 weeks on a 24-week plan paid up front, compounded
Tirzepatide / month
$269 per 4 weeksMonth-to-month, same at every dose; $225 per 4 weeks on a 24-week plan paid up front, compounded
Index 82/100 · Grade B−Checked October 2026

Compounded drugs are not FDA-approved. Understand the medication options.

Check REMEVi pricing Read review

We may earn a commission if you sign up through a provider link, at no extra cost to you. Compensation does not change scores. How we earn money.

The comparison in brief

OurView Health has the higher Cost-Efficiency Index: 83/100 versus 82/100. That is a value comparison under our published methodology, not a measure of medical suitability or a guarantee of results.

Check the difference in state access

OurView Health
46 states plus DC (excludes AR, CT, HI and NJ)
REMEVi
49 states + DC

The better fit depends on what is included in your quote. A lower advertised price can require prepayment, apply to a starting dose or leave out a separate fee.

How the comparison is scored

Costs & coverage

Published prices with their terms intact. Annual estimates account for billing frequency and known fixed required fees; they are not a treatment quote.

OurView Health

REMEVi

Semaglutide / month
OurView Health: $109/moAny dose, compounded; $297 prepaid for three months
REMEVi: $199 per 4 weeksMonth-to-month, same at every dose; $159 per 4 weeks on a 24-week plan paid up front, compounded
Tirzepatide / month
OurView Health: $129/moAny dose, compounded; $357 prepaid for three months
REMEVi: $269 per 4 weeksMonth-to-month, same at every dose; $225 per 4 weeks on a 24-week plan paid up front, compounded
Semaglutide / year (modeled)
OurView Health: $1,308
REMEVi: $2,58713 charges
Tirzepatide / year (modeled)
OurView Health: $1,548
REMEVi: $3,49713 charges
State availability
OurView Health: 46 states plus DC (excludes AR, CT, HI and NJ)
REMEVi: 49 states + DC
Oral / sublingual option listed
OurView Health: Not listed
REMEVi: Yes
Brand-name access listed
OurView Health: Not confirmed
REMEVi: Not confirmed
Provider facts checked
OurView Health: October 2026
REMEVi: October 2026

Comparing different billing plans? See what a GLP-1 monthly price can leave out, or calculate the monthly cost.

Which program fits your priorities?

The strengths and limitations behind each provider's score. Read the full review before deciding.

OurView Health

Patients who want a published flat dose price and can choose monthly or prepaid quarterly billing.

Reasons to consider it

  • Any-dose monthly plans cost $109 for semaglutide or $129 for tirzepatide
  • Three-month prepayment saves $30 on either drug
  • No membership fee; medication ships after provider approval

What to weigh up

  • Three-month discounts require payment up front
  • Service excludes Arkansas, Connecticut, Hawaii and New Jersey
  • Dispensed medication cannot be returned for a refund

Compounded drugs are not FDA-approved. Understand the medication options.

Check OurView Health pricing Read the full OurView Health review

REMEVi

Spanish- and English-speaking shoppers who want LegitScript-certified compounded GLP-1 care in their own language.

Reasons to consider it

  • A genuinely flat rate: 'the same price at every dose', stated as such, with no dose upcharge and no introductory rate to step off
  • Longer terms are published openly rather than used as a teaser: semaglutide falls to $169 every 4 weeks on a 12-week plan and $159 on a 24-week plan
  • A daily oral semaglutide tablet is offered alongside the injection

What to weigh up

  • Billing runs every 4 weeks, so a year of month-to-month care is 13 charges, and the lowest $159 rate needs 24 weeks paid up front
  • No FDA-approved brand-name pathway — the Wegovy and Ozempic pages are comparison content, not products
  • Compounded semaglutide and tirzepatide are not FDA-approved finished products

Compounded drugs are not FDA-approved. Understand the medication options.

Check REMEVi pricing Read the full REMEVi review

Explore the six scoring factors

Scores run from 0 to 100. A higher factor score reflects our published value criteria; it is not a clinical endorsement.

OurView HealthREMEVi
Normalized Cost/Month
OurView Health:
92/100
REMEVi:
74/100
Price Transparency
OurView Health:
97/100
REMEVi:
94/100
Nationwide Access
OurView Health:
78/100
REMEVi:
86/100
Formulation Options
OurView Health:
66/100
REMEVi:
77/100
Clinical Oversight
OurView Health:
80/100
REMEVi:
87/100
Contract Flexibility
OurView Health:
69/100
REMEVi:
69/100

Before you sign up

  • Confirm your totalAsk about dose changes, membership, labs, shipping and cancellation terms.
  • Check treatment accessState coverage and medical eligibility can differ by medication and formulation.
  • Understand the medicationCompare compounded and brand-name options. Compounded drugs are not FDA-approved.

Keep comparing

Alternatives to OurView HealthAlternatives to REMEVi
More provider matchups
CoreAge Rx vs OurView HealthCoreAge Rx vs REMEVi
Choose a different comparison

Provider information reflects public disclosures at the verification dates shown. Prices and availability change; confirm current terms before paying. This comparison is for information, not medical advice. A licensed clinician determines whether treatment is appropriate.